http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Cancer vaccines as immunotherapy of cancer
Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches. The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.
1. Introduction; 2. Identification of Tumor Associated Antigens; 3. Identification of Tumor Specific Antigens; 4. Proteogenomics for identification of novel target tumor antigens; 5. Antigen-specific T cells; 6. Tumor antigens for preventive strategies; 7. Peptide based vaccines; 8. RNA based vaccines; 9. Novel dendritic cells strategies; 10. Oncolytic viruses for antigen delivery; 11. Cancer vaccine targeting viral antigens; 12. Combinatorial immunotherapy strategies; 13. Conclusions
edited by Luigi Buonaguro, Sjoerd Van Der Burg.